ExThera Medical Corporation announces that it has received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA), for its Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100). Learn more 👉https://lnkd.in/ggaBfMq3 #healthcare
ExThera Medical’s Post
More Relevant Posts
-
Head of Marketing DACH, BeNeLux and Nordics for Clinical Effectiveness, Wolters Kluwer Health at Wolters Kluwer
Good medication decision support focuses on the most significant adverse drug events. My colleague, Israel Armstrong from Wolters Kluwer, explains the opportunity from improving the digital foundations across Europe and the value of introducing decision support into #pharmacy workflows. Watch his HIMSS TV interview: https://lnkd.in/eBaJV2sj #MediSpan
To view or add a comment, sign in
-
-
Good medication decision support focuses on the most significant adverse drug events. My colleague, Israel Armstrong from Wolters Kluwer, explains the opportunity from improving the digital foundations across Europe and the value of introducing decision support into #pharmacy workflows. Watch his HIMSS TV interview: https://lnkd.in/geJdJvTT #MediSpan
To view or add a comment, sign in
-
-
🚀 Exciting News Alert! 🚀 Join Total Pharmacy for an exclusive virtual event focused on Elevating Patient-Centric Care! 🏥 Dive into educational sessions and earn 1.50+ CE credits - all at no cost! Stay tuned for more updates on our Keynote speaker and special guest MC. Don't miss out - register now in the comments below! #Pharmacy #IndependentPharmacy #PatientCentricCare #PharmacyExcellence #CECredits #VirtualLearning Drug Topics
To view or add a comment, sign in
-
-
Scientists at the FDA continue to monitor drugs for safety and effectiveness, even after they are approved and available to patients. This includes collecting information from drug makers, health care professionals, and patients and updating drug labels and warnings as needed. Learn more about this process in FDA’s latest video. https://lnkd.in/e9Gik5_e
To view or add a comment, sign in
-
Good medication decision support focuses on the most significant adverse drug events. My colleague, Israel Armstrong from Wolters Kluwer, explains the opportunity from improving the digital foundations across Europe and the value of introducing decision support into #pharmacy workflows. Watch his HIMSS TV interview: https://lnkd.in/dKVUC5wN #MediSpan
To view or add a comment, sign in
-
-
Tracking efficacy and safety continues after drugs are approved and on the market. Video below
Scientists at the FDA continue to monitor drugs for safety and effectiveness, even after they are approved and available to patients. This includes collecting information from drug makers, health care professionals, and patients and updating drug labels and warnings as needed. Learn more about this process in FDA’s latest video. https://lnkd.in/e9Gik5_e
To view or add a comment, sign in
-
Traditional drug interaction systems don't consider the risk or results of drug-gene interactions. GalenusRx's APPRAISE™ platform does. It's one of five key factors that can limit the safety and efficacy of medication regimens. Our medication safety platform assesses all five. Learn more about we're addressing the global problem of adverse drug events with a comprehensive solution: https://galenusrx.com/ #Pharmacogenomics #MedicationSafety #HealthcareInnovation #HealthTech #MedTech
5 Factors of Drug Interactions, Part 3: Drug-Gene
To view or add a comment, sign in
-
Gazette: EDITORIAL: Capping Colorado’s prescription costs will backfire: If only there were a magic wand to tame the high cost of living in our inflationary economy. Instead, there are politicians — who merely pretend to possess such superhuman power. And their attempts to wield it inevitably backfire, sooner or later. Thus, our sense of impending doom after news that another high-priced prescription drug was officially declared “unaffordable” by Colorado’s groundbreaking Prescription Drug Affordability Review Board. The finding last Friday paves the way for the drug board to set an upper price limit that could be charged for the drug in our state. … As reported Monday in The Gazette by the Colorado Chamber of Commerce’s Sum & Substance news service, the board’s action was directed at Stelara, a medication that treats anti-inflammatory diseases affecting joints and bowels. It was developed and is manufactured by pharmaceutical giant Johnson & Johnson, and demand for it has been on the rise. Read more here. http://dlvr.it/T8Drr1 #Timnath #Colorado #TimnathChamber
To view or add a comment, sign in
-
Take control of your healthcare costs, Discover the ease of comparing drug prices. REGISTER TODAY AT www.rxpowered.com Get your convenient solution to finding affordable 💊medicine!! #rxpowered #rxpoweredmemberbenifits #discounts #rxsavingscard #prescriptionsavings #medicationmanagement #pharmacy
To view or add a comment, sign in
-
-
Risk Management Consultant | Business Development Specialist | Strategist | Helping forward-thinking organizations build strategies for long-term success!
📢 Attention professionals in the healthcare industry! 📢 Mark your calendars 🗓️ The next Prescription Drug Data Collection (RxDC) report is due by Saturday, June 1, 2024. Stay ahead of the curve with our latest Legal Update, spotlighting this crucial upcoming deadline. Keeping abreast of these deadlines ensures compliance and smooth operations in the dynamic landscape of healthcare. Stay tuned for more insights and updates! #HealthcareIndustry #RxDC #ComplianceDeadline #StayUpdated
To view or add a comment, sign in